Bp Plc maintained its position in shares of Johnson & Johnson (NYSE:JNJ) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 318,000 shares of the company’s stock at the close of the second quarter. Johnson & Johnson makes up 1.5% of Bp Plc’s holdings, making the stock its 5th largest holding. Bp Plc’s holdings in Johnson & Johnson were worth $42,075,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Lenox Wealth Advisors Inc. increased its holdings in Johnson & Johnson by 0.6% during the 2nd quarter. Lenox Wealth Advisors Inc. now owns 876 shares of the company’s stock valued at $116,000 after purchasing an additional 5 shares during the period. Harel Insurance Investments & Financial Services Ltd. increased its holdings in Johnson & Johnson by 241.0% during the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 1,190 shares of the company’s stock valued at $149,000 after purchasing an additional 841 shares during the period. Ullmann Financial Group Inc. purchased a new position in Johnson & Johnson during the 1st quarter valued at about $186,000. Taylor Wealth Management Partners increased its holdings in Johnson & Johnson by 19.8% during the 1st quarter. Taylor Wealth Management Partners now owns 1,510 shares of the company’s stock valued at $188,000 after purchasing an additional 250 shares during the period. Finally, Puplava Financial Services Inc. purchased a new position in Johnson & Johnson during the 2nd quarter valued at about $202,000. Hedge funds and other institutional investors own 65.93% of the company’s stock.
A number of research analysts recently issued reports on JNJ shares. BMO Capital Markets restated a “buy” rating and set a $145.00 price target on shares of Johnson & Johnson in a report on Friday, September 1st. UBS AG restated a “buy” rating and set a $148.00 price target on shares of Johnson & Johnson in a report on Thursday, August 31st. Cowen and Company set a $147.00 price target on Johnson & Johnson and gave the company a “buy” rating in a report on Thursday, August 24th. Credit Suisse Group restated a “buy” rating on shares of Johnson & Johnson in a report on Friday, August 4th. Finally, Zacks Investment Research upgraded Johnson & Johnson from a “hold” rating to a “buy” rating and set a $148.00 price target on the stock in a report on Thursday, July 27th. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and eleven have given a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $143.70.
TRADEMARK VIOLATION WARNING: “Bp Plc Holds Holdings in Johnson & Johnson (JNJ)” was first posted by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://transcriptdaily.com/2017/11/18/bp-plc-holds-holdings-in-johnson-johnson-jnj.html.
Johnson & Johnson (NYSE JNJ) opened at $138.00 on Friday. Johnson & Johnson has a 1-year low of $109.32 and a 1-year high of $144.35. The firm has a market cap of $373,080.00, a P/E ratio of 19.54, a P/E/G ratio of 2.83 and a beta of 0.82. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.32 and a quick ratio of 1.02.
Johnson & Johnson (NYSE:JNJ) last announced its quarterly earnings data on Tuesday, October 17th. The company reported $1.90 earnings per share for the quarter, topping analysts’ consensus estimates of $1.80 by $0.10. Johnson & Johnson had a net margin of 21.28% and a return on equity of 27.38%. The company had revenue of $19.65 billion during the quarter, compared to analyst estimates of $19.29 billion. During the same period in the previous year, the business earned $1.68 EPS. The firm’s revenue for the quarter was up 10.3% on a year-over-year basis. analysts anticipate that Johnson & Johnson will post 7.28 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Tuesday, November 28th will be issued a $0.84 dividend. The ex-dividend date of this dividend is Monday, November 27th. This represents a $3.36 dividend on an annualized basis and a yield of 2.43%. Johnson & Johnson’s payout ratio is currently 58.33%.
Johnson & Johnson Company Profile
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.
Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.